Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21566653rdf:typepubmed:Citationlld:pubmed
pubmed-article:21566653lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C1172465lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C1705660lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C0012860lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C1415406lld:lifeskim
pubmed-article:21566653lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:21566653pubmed:issue8lld:pubmed
pubmed-article:21566653pubmed:dateCreated2011-8-10lld:pubmed
pubmed-article:21566653pubmed:abstractTextDNA double-strand breaks (DSBs) are deleterious lesions that can lead to chromosomal anomalies, genomic instability and cancer. The histone protein H2AX has an important role in the DNA damage response (DDR) and the presence of phospho-H2AX (?H2AX) nuclear foci is the hallmark of DSBs. We hypothesize that ongoing DNA damage provides a mechanism by which chromosomal abnormalities and intratumor heterogeneity are acquired in malignant plasma cells (PCs) in patients with multiple myeloma (MM). Therefore, we assessed PCs from patients with the premalignant condition, monoclonal gammopathy of undetermined significance (MGUS) and MM, as well as human MM cell lines (HMCLs) for evidence of DSBs. ?H2AX foci were detected in 2/5 MGUS samples, 37/40 MM samples and 6/6 HMCLs. Notably, the DSB response protein 53BP1 colocalized with ?H2AX in both MM patient samples and HMCLs. Treatment with wortmannin decreased phosphorylation of H2AX and suggests phosphoinositide (PI) 3-kinases and/or PI3-kinase-like family members underlie the presence of ?H2AX foci in MM cells. Taken together, these data imply that ongoing DNA damage intensifies across the disease spectrum of MGUS to MM and may provide a mechanism whereby clonal evolution occurs in the monoclonal gammopathies.lld:pubmed
pubmed-article:21566653pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:languageenglld:pubmed
pubmed-article:21566653pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:citationSubsetIMlld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21566653pubmed:statusMEDLINElld:pubmed
pubmed-article:21566653pubmed:monthAuglld:pubmed
pubmed-article:21566653pubmed:issn1476-5551lld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:HendersonK...lld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:WaltersD KDKlld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:JogN VNVlld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:JelinekD FDFlld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:TschumperR...lld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:DispenzieriAAlld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:ArendtB KBKlld:pubmed
pubmed-article:21566653pubmed:authorpubmed-author:HuddlestonP...lld:pubmed
pubmed-article:21566653pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21566653pubmed:volume25lld:pubmed
pubmed-article:21566653pubmed:ownerNLMlld:pubmed
pubmed-article:21566653pubmed:authorsCompleteYlld:pubmed
pubmed-article:21566653pubmed:pagination1344-53lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:meshHeadingpubmed-meshheading:21566653...lld:pubmed
pubmed-article:21566653pubmed:year2011lld:pubmed
pubmed-article:21566653pubmed:articleTitleEvidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX.lld:pubmed
pubmed-article:21566653pubmed:affiliationDepartment of Immunology, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA.lld:pubmed
pubmed-article:21566653pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21566653pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:3014entrezgene:pubmedpubmed-article:21566653lld:entrezgene
entrez-gene:7158entrezgene:pubmedpubmed-article:21566653lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21566653lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21566653lld:entrezgene